The GO-BP and KEGG enrichment analysis of the key targets revealed that STT exerts its therapeutic effect on psoriasis through multiple BPs and signaling pathways, including Th17 cell differentiation, JAK-STAT, mitogen-activated protein kinase, and adipocytokine signaling pathways. The gene discussed is WNK2; the disease is Bartsocas-Papas syndrome 1.